ArticlePloS one2019

Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia.

Lucia Taramasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.